At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4007 Pharmacy
Trading 10-21 10:53:02 EDT
1,006.09
-7.92
-0.78%
High1,013.97Low1,003.05Vol293.21M
Open1,013.97D1 Closing1,014.01Amplitude1.08%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O2.58BT/O Rate--Tradable Shares0.00
P/B4.334952ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Eli Lilly & Co (LLY) and Sanofi (OtherSNYNF)
TIPRANKS  ·  21:50
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Eli Lilly & Co (LLY) and Sanofi (OtherSNYNF)
Lexaria Bioscience reaches full enrollment in GLP-1-H26-7 study
TIPRANKS  ·  21:35
Lexaria Bioscience reaches full enrollment in GLP-1-H26-7 study
NVIDIA, Microsoft, Merck KGaA Collaborate on AI Patient Support Model
MT Newswires Live  ·  21:33
NVIDIA, Microsoft, Merck KGaA Collaborate on AI Patient Support Model
Jaguar says crofelemer shows benefit for IF in congenital enteropathy disorder
TIPRANKS  ·  21:25
Jaguar says crofelemer shows benefit for IF in congenital enteropathy disorder
Lexaria Bioscience Reaches Full Enrollment in Oral Semaglutide Study
Reuters  ·  21:25
Lexaria Bioscience Reaches Full Enrollment in Oral Semaglutide Study
Press Release: Decibel Comments on Tender Offer by Ewing Morris for up to 6.8% of Common Shares at $1.91 Per Share
Dow Jones  ·  21:24
Press Release: Decibel Comments on Tender Offer by Ewing Morris for up to 6.8% of Common Shares at $1.91 Per Share
GSK’s ViiV announce real-world evidence from OPERA cohort using Cabenuva
TIPRANKS  ·  21:20
GSK’s ViiV announce real-world evidence from OPERA cohort using Cabenuva
Kazia Therapeutics Initiated at Buy by Guggenheim
Dow Jones  ·  21:19
Kazia Therapeutics Initiated at Buy by Guggenheim
Eli Lilly price target raised to $1,316 from $1,309 at Leerink
TIPRANKS  ·  21:15
Eli Lilly price target raised to $1,316 from $1,309 at Leerink
Jaguar Health's Crofelemer Reduces Daily Parenteral Support Needs by About 15% in Infant with Congenital Sodium Diarrhea
Reuters  ·  21:07
Jaguar Health's Crofelemer Reduces Daily Parenteral Support Needs by About 15% in Infant with Congenital Sodium Diarrhea
Neonc Technologies, Department of Health – Abu Dhabi Sign MoU to Advance Brain Cancer Research
Reuters  ·  20:37
Neonc Technologies, Department of Health – Abu Dhabi Sign MoU to Advance Brain Cancer Research
Press Release: Evolus to Report Third Quarter Financial Results on November 4, 2026
Dow Jones  ·  20:32
Press Release: Evolus to Report Third Quarter Financial Results on November 4, 2026
Lexicon's Sotagliflozin Improves Cardiac Function in Mouse Study of Hypertrophic Cardiomyopathy
Reuters  ·  20:31
Lexicon's Sotagliflozin Improves Cardiac Function in Mouse Study of Hypertrophic Cardiomyopathy
Perrigo Sets Third-Quarter Results Release
Reuters  ·  20:30
Perrigo Sets Third-Quarter Results Release
Evolus Schedules Third-Quarter Financial Results Release
Reuters  ·  20:30
Evolus Schedules Third-Quarter Financial Results Release
Lexicon Pharmaceuticals Announces Publication of New Research Highlighting Sotagliflozin’s Biological Effects in Cardiovascular Disease
GlobeNewswire  ·  20:30
Lexicon Pharmaceuticals Announces Publication of New Research Highlighting Sotagliflozin’s Biological Effects in Cardiovascular Disease
Enveric Biosciences Announces Positive Results from IND-Enabling ADMET Studies
Reuters  ·  20:29
Enveric Biosciences Announces Positive Results from IND-Enabling ADMET Studies
Genentech announces new Phase III data for fenebrutinib
TIPRANKS  ·  20:20
Genentech announces new Phase III data for fenebrutinib
Enveric Biosciences Reports Positive Preclinical Study Results for EB-003
Reuters  ·  20:06
Enveric Biosciences Reports Positive Preclinical Study Results for EB-003
Collegium to Present Phase 4 Azstarys Studies in Children with ADHD
Reuters  ·  20:06
Collegium to Present Phase 4 Azstarys Studies in Children with ADHD

Introduction

Company Name.
BK4007
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--